Tuesday, June 20, 2017

Clinically Tested: Palbociclib and Me

I've never been in a clinical trial before, but I vividly remember the Gray's Anatomy episode in which Meredith--wanting to help Adele, who has Alzheimer's--manages to make sure Adele gets the real McCoy, not the saline solution. I got handed a bottle with a number on it--I have my very own four-digit number for the duration of the trial, so that neither I nor the doctors know whether I am getting the real thing. 
Except that I obviously am: I didn't bother with Dr. Google until the nurse called to let me know my white blood cell count was "too low" to continue this week, and my count was fine before. I hadn't noticed any side effects apart from the usual, the fatigue I can't quite shake, although my new hair did seem to be growing more slowly . . . I'd gone from fuzz to something approaching Jimi Hendrix within weeks, and now there was nothing going on up there.
I'm not supposed to eat grapefruit. I don't. But I crave oranges and consume them frequently. 
I'm wondering whether the statistics that seem to tell the tale are correct in my case. Statistically speaking (but I had to read How To Lie With Statistics in sixth grade) I am in exactly the category likelier to survive longer without a recurrence of cancer if I continue with the clinical trial. But now that I think about the situation, I've felt tireder ever since I began what must be Palbociclib.
Anyone out there experienced with this medicine?

No comments:

Post a Comment